IL-17 expression is correlated with hepatitis B-related liver diseases and fibrosis

International Journal of Molecular Medicine

Volumn 27, Issue 3, 2011, Pages 385-392

  Wang, Liyun ^a   Chen, Shijun ^a,b   Xu, Keshu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Hospital for Infectious Diseases   (China)

Author keywords

Hepatitis B; IL 17; Liver cirrhosis; Liver fibrosis; T cell

Indexed keywords

COLLAGEN TYPE 3; COLLAGEN TYPE 4; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HYALURONIC ACID; INTERLEUKIN 17; INTERLEUKIN 4; LAMININ; PROCOLLAGEN; RNA; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADULT; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKIN-17; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED;

EID: 79551600761     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.594     Document Type: Article

References (25)

1. Infante-Duarte C, Horton HF, Byrne MC and Kamradt T: Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 165: 6107-6115, 2000.
2. Langrish CL, Chen Y, Blumenschein WM, et al: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233-240, 2005.
3. Park H, Li Z, Yang XO, et al: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 Nat Immunol 6: 1133-1141, 2005.
4. Lafdil F, Miller AM, Ki SH and Gao B: Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol 7: 250-254, 2010.
5. Lemmers A, Moreno C, Gustot T, et al: The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49: 646-657, 2009.
6. Zhang JY, Zhang Z, Lin F, et al: Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 51: 81-91, 2010.
7. Holt AP, Salmon M, Buckley CD and Adams DH: Immune interactions in hepatic fibrosis. Clin Liver Dis 12: 861-882, 2008.
8. Lok AS and McMahon BJ: Chronic hepatitis B. Hepatology 45: 507-539, 2007
9. Beckebaum S, Cicinnati VR, Zhang X, et al: Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology 109: 487-495, 2003.
10. Freeman AJ, Marinos G, Ffrench RA and Lloyd AR: Immunopathogenesis of hepatitis C virus infection. Immunol Cell Biol 79: 515-536, 2001.
11. Kolls JK and Linden A: Interleukin-17 family members and inflammation. Immunity 21: 467-476, 2004.
12. Nakae S, Saijo S, Horai R, Sudo K, Mori S and Iwakura Y: IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci USA 100: 5986-5990, 2003. (Pubitemid 36576918)
13. Hou W, Kang HS and Kim BS: Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J Exp Med 206: 313-328, 2009.
14. Friedman SL: Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328: 1828-1835, 1993.
15. Olaso E and Friedman SL: Molecular regulation of hepatic fibrogenesis. J Hepatol 29: 836-847, 1998.
16. Szabo G, Mandrekar P and Dolganiuc A: Innate immune response and hepatic inflammation. Semin Liver Dis 27: 339-350, 2007
17. Bertoletti A and Naoumov NV: Translation of immunological knowledge into better treatments of chronic hepatitis B. J Hepatol 39: 115-124, 2003.
18. Guidotti LG and Chisari FV: Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19: 65-91, 2001.
19. Gressner AM and Weiskirchen R: Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 10: 76-99, 2006.
20. Kopp J, Seyhan H, Muller B, et al: N-acetyl-L-cysteine abrogates fibrogenic properties of fibroblasts isolated from Dupuytren's disease by blunting TGF-beta signalling. J Cell Mol Med 10: 157-165, 2006.
21. Veldhoen M and Stockinger B: TGFbeta1, a 'Jack of all trades': the link with pro-inflammatory IL-17-producing T cells. Trends Immunol 27: 358-361, 2006.
22. Qin H, Wang L, Feng T, et al: TGF-beta promotes Th17 cell development through inhibition of SOCS3. J Immunol 183: 97-105, 2009.
23. Bettelli E, Carrier Y, Gao W, et al: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238, 2006.
24. Henri S, Chevillard C, Mergani A, et al: Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease. J Immunol 169: 929-936, 2002.
25. Booth M, Mwatha JK, Joseph S, et al: Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender. J Immunol 172: 1295-1303, 2004.